Raymond James Financial
RMD icon

Raymond James Financial’s ResMed RMD Stock Holding History

Raymond James Financial’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.3M Buy
59,196
+1,717
+3% +$428K ﹤0.01% 1782
2025
Q4 		$13.8M Buy
57,479
+3,670
+7% +$939K ﹤0.01% 1712
2025
Q3 		$14.7M Buy
53,809
+5,697
+12% +$1.56M ﹤0.01% 1632
2025
Q2 		$12.4M Buy
48,112
+5,242
+12% +$1.25M ﹤0.01% 1714
2025
Q1 		$9.6M Buy
42,870
+1,075
+3% +$251K ﹤0.01% 1839
2024
Q4 		$9.56M Buy
+41,795
New +$10.1M ﹤0.01% 1885

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Raymond James Financial's RMD Position: Q1 2026 in Review

Raymond James Financial increased its ResMed (RMD) stake by 3% in Q1 2026, buying an estimated $428K and bringing the position to 59,196 shares worth $13.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1782.

Raymond James Financial first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $14.7M in Q3 2025. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Raymond James Financial held 59,196 shares of ResMed worth $13.3M as of Q1 2026.
  • Raymond James Financial bought 1,717 ResMed shares in Q1 2026, an estimated $428K.
  • ResMed made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #1782 holding.
  • Raymond James Financial first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's ResMed position peaked at $14.7M in Q3 2025.
  • 940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.